YuYi peptide
Retatrutide
Finnrick tested 3 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from YuYi peptide between 29 Dec 2025 and 22 Jan 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
YuYi peptide
Retatrutide
Tested 3 Samples
Last test 22 Jan 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from YuYi peptide
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
22 Jan 2026
First
29 Dec 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 22 Jan 2026 | View | 10mg | 9.8mg | -2.0% | 99.80% | (no batch ID) | White Label / Silver Crimp / Green Cap | Lab G | Public | |
| 15 Jan 2026 | View | 10mg | 9.9mg | -1.0% | 99.70% | (no batch ID) | No Label / Silver Crimp / Teal Cap | Lab G | Public | |
| 29 Dec 2025 | View | 10mg | ⚠️ Sample does not contain Retatrutide | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |||